0.2963
price down icon4.42%   -0.0137
pre-market  Vorhandelsmarkt:  .29   -0.0063   -2.13%
loading

Finanzdaten der Leap Therapeutics Inc-Aktie (LPTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
6.06%
16.88
15.92 16.12 17.86 21.25
Operating Income/Loss
6.06%
-16.88
-15.92 -16.12 -17.86 -21.25
Income/Loss From Continuing Operations Before Tax
7.83%
-16.64
-15.44 -15.55 -17.47 -20.13
Income/Loss From Continuing Operations After Tax
7.83%
-16.64
-15.44 -15.43 -18.18 -20.13
Net Income/Loss
7.83%
-16.64
-15.44 -15.43 -18.18 -20.13
Preferred Stock Dividends And Other Adjustments
-
- - - 0.234
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.43%
41.44
41.27 1.2428 41.21 39.12
Diluted Average Shares
0.43%
41.44
41.27 1.2428 41.21 39.12
Basic Earnings Per Share
8.11%
-0.40
-0.37 -0.37 -0.44 -0.52
Diluted Earnings Per Share
8.11%
-0.40
-0.37 -0.37 -0.44 -0.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - 0.234
$24.54
price up icon 0.95%
$84.00
price down icon 0.90%
$26.98
price up icon 2.70%
$104.79
price down icon 0.27%
$132.17
price up icon 3.00%
biotechnology ONC
$308.91
price up icon 0.09%
Kapitalisierung:     |  Volumen (24h):